Overview

Specified Drug Use-results Survey of Graceptor in Patients With Kidney Transplantation (Switching From Cyclosporine)

Status:
Completed
Trial end date:
2016-03-31
Target enrollment:
Participant gender:
Summary
To evaluate the safety and efficacy of Graceptor ® in patients with kidney transplantation when converted from cyclosporine
Details
Lead Sponsor:
Astellas Pharma Inc
Treatments:
Cyclosporine
Cyclosporins
Tacrolimus